WuXi Global Forum 2024


Dear colleagues and friends,


It was a great honor for us to host many of you from around the world in San Francisco for the 12th WuXi Global Forum on January 9, 2024, coinciding with the 2024 J.P. Morgan Healthcare Conference. 


The theme of this year’s forum is B.O.L.D. We reflected on the state of innovation and highlighted our industry’s notable advances in tackling innovation challenges to build an impactful future for patients: Breaking BarriersOpening New HorizonsLeading Next Generation and Delivering on the Promise for Patients.


Special thanks to our supportive partners: A*STARBioCenturyBiocom CaliforniaBioWorldCalifornia Life SciencesDavos Alzheimer's CollaborativeEndpoints NewsGENMedicon Valley AllianceSwiss Biotech Association and UK BioIndustry Association.




11:30 AM - 01:30 PM Badge Pickup and Onsite Check-in


01:30 PM - 01:35 PM Welcome

Hui Cai, Program Chair and Vice President, WuXi AppTec


01:35 PM - 01:45 PM Opening Remarks

Minzhang Chen, Co-CEO, WuXi AppTec


01:45 PM - 02:30 PM State of Innovation 2024

Amy Abernethy, CMO & President, Product Development, Verily

Donald Ingber, Founding Director & Chaired Professor, Wyss Institute at Harvard University

Mathai Mammen, CEO & Chairman, FogPharma

John Maraganore, CEO, JMM Innovations

Søren Møller, Managing Partner, Seed Investments, Novo Holdings

Session Leader: Christoph Westphal, Co-Founder & General Partner, Longwood Fund


Spotlight on B.O.L.D.


02:30 PM - 03:00 PM Breaking Barriers. Leaping Forward.

Robert Gabbay, CSO & CMO, American Diabetes Association

Karen Knudsen, CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health

Joseph Wu, President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences

Session Leader: Margo Georgiadis, Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering


03:00 PM - 03:45 PM Opening Up New Horizons: Spotlight on Cancer

Philip Kantoff, Co-Founder & CEO, Convergent Therapeutics

Samir Khleif, Founder & CEO, Georgiamune

Crystal Mackall, Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy

Briggs Morrison, CEO, Crossbow Therapeutics

Session Leader: Karen Tkach Tuzman, Director, Biopharma Intelligence, BioCentury


03:45 PM - 04:30 PM Leading Transformation: The Next Wave Therapeutics

Wolfram Carius, EVP Pharmaceuticals, Bayer

Abraham Ceesay, CEO, Rapport Therapeutics

Pavan Cheruvu, President & CEO, Bitterroot Bio

Giuseppe “Pino” Ciaramella, Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics

Kevin Forrest, Co-Founder, President & CEO, Kate Therapeutics

Amber Salzman, CEO, Epic Bio

Session Leader: Edward Hu, Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies


04:30 PM - 05:15 PM Delivering on Future Platform Solutions

Miles Congreve, CSO, Isomorphic Labs

Evan Feinberg, Co-Founder & CEO, Genesis Therapeutics

Nevan Krogan, Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes

Ann Lee-Karlon, President & CEO, EpiBiologics

Sabrina Yang, Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering

Session Leader: John Carroll, Editor & Founder, Endpoints News


05:15 PM - 06:00 PM Scaling Breakthroughs Forward

Vineeta Agarwala, General Partner, Andreessen Horowitz (a16z) Bio + Health

Alexis Borisy, Co-Founder & Chairman, Curie.Bio

Laura Furmanski, Partner, Patient Square Capital

Rogier Rooswinkel, General Partner, Forbion

Tim Shannon, General Partner, Canaan

John Wesley, Investment Director, NVentures

Session Leader: Steve Yang, Co-CEO, WuXi AppTec


06:00 PM - 07:00 PM Forum Closing and Reception


Please click here for the speaker bio